ChemDiv and Institut Pasteur Korea Announce Partnership


ChemDiv, Inc. (ChemDiv), and Institut Pasteur Korea (IPK) announced that they have entered into collaboration for the discovery and development of new drugs against tuberculosis disease (TB).

Under the terms of this collaboration, ChemDiv will provide IPK with its research small molecules series for TB. ChemDiv will contribute other services of its Discovery outSource platform. IPK will contribute its unique high content and throughput visual TB assays, as well as animal models for TB drug discovery.

Other news from the department science

Most read news

More news from our other portals